Australia markets open in 4 hours 43 minutes

Sorrento Therapeutics, Inc. (SRNE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.8050-0.3650 (-8.75%)
At close: 04:00PM EST
3.7500 -0.06 (-1.45%)
After hours: 07:58PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts2122
Avg. Estimate-0.29-0.16-1.26-0.57
Low estimate-0.32-0.16-1.29-0.71
High estimate-0.27-0.16-1.23-0.43
Year ago EPS-0.270.01-1.3-1.26
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts2122
Avg. Estimate15.13M35.5M54.96M103.21M
Low estimate12M35.5M51.83M13.63M
High estimate18.25M35.5M58.1M192.8M
Year ago sales11.51M14.26M39.99M54.96M
Sales growth (year/est)31.50%149.00%37.40%87.80%
Earnings history30/12/202030/03/202129/06/202129/09/2021
Est. EPS2.710.38-0.2-0.23
Actual EPS-0.270.01-0.57-0.4
Difference-2.98-0.37-0.37-0.17
Surprise %-110.00%-97.40%-185.00%-73.90%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Current estimate-0.29-0.16-1.26-0.57
7 days ago-0.29-0.16-1.26-0.57
30 days ago-0.23-0.17-0.911.66
60 days ago-0.23-0.17-0.911.66
90 days ago-0.230.32-0.911.66
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days11N/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesSRNEIndustrySector(s)S&P 500
Current qtr.-7.40%N/AN/AN/A
Next qtr.-1,700.00%N/AN/AN/A
Current year3.10%N/AN/AN/A
Next year54.80%N/AN/AN/A
Next 5 years (per annum)37.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A